Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley–Lewis, David Aguilar, Matthew C. Riddle, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Hertzel C. Gerstein, Peter Johnston, Lars Køber, Francesca Lawson,

American Heart Journal · 2015 · 99 citations · 41 references

DOIFull text

Open access

Concepts

References

41